AI designs complete viral genomes, sparking therapy promise and biosafety concerns
Researchers used AI to design complete bacteriophage genomes, selecting 302 designs and confirming 16 that kill E. coli in the lab; this marks the first time a complete viral genome was designed by AI and could accelerate phage therapy and drug development, but raises urgent biosafety and biosecurity concerns that require safeguards.

